These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 25304170)

  • 41. Alpha-synuclein pathology in the olfactory pathways of dementia patients.
    Hubbard PS; Esiri MM; Reading M; McShane R; Nagy Z
    J Anat; 2007 Jul; 211(1):117-24. PubMed ID: 17553102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Olfactory Trail of Neurodegenerative Diseases.
    Franco R; Garrigós C; Lillo J
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modern psychophysical tests to assess olfactory function.
    Eibenstein A; Fioretti AB; Lena C; Rosati N; Amabile G; Fusetti M
    Neurol Sci; 2005 Jul; 26(3):147-55. PubMed ID: 16086127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between olfaction and higher cortical functions in Alzheimer's disease, mild cognitive impairment, and healthy older adults.
    Ward AM; Calamia M; Thiemann E; Dunlap J; Tranel D
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):646-658. PubMed ID: 27868477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Odor identification deficits identify Parkinson's disease patients with poor cognitive performance.
    Damholdt MF; Borghammer P; Larsen L; Ostergaard K
    Mov Disord; 2011 Sep; 26(11):2045-50. PubMed ID: 21638326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's disease.
    Kjelvik G; Sando SB; Aasly J; Engedal KA; White LR
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):1020-4. PubMed ID: 17299804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment.
    Fatuzzo I; Niccolini GF; Zoccali F; Cavalcanti L; Bellizzi MG; Riccardi G; de Vincentiis M; Fiore M; Petrella C; Minni A; Barbato C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Olfactory dysfunction in Parkinson's disease.
    Wszolek ZK; Markopoulou K
    Clin Neurosci; 1998; 5(2):94-101. PubMed ID: 10785834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olfaction in neurodegenerative disorder.
    Hawkes C
    Mov Disord; 2003 Apr; 18(4):364-72. PubMed ID: 12671941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Presymptomatic detection of Parkinson's disease].
    Berendse HW; Booij J; Stoffers D; Ponsen MM; Hijman R; Wolters ECh
    Tijdschr Gerontol Geriatr; 2002 Apr; 33(2):70-7. PubMed ID: 12012945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemosensory perception is specifically impaired in Parkinson's disease.
    Tremblay C; Durand Martel P; Frasnelli J
    Parkinsonism Relat Disord; 2018 Dec; 57():68-71. PubMed ID: 30100363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.
    Rey NL; Jardanhazi-Kurutz D; Terwel D; Kummer MP; Jourdan F; Didier A; Heneka MT
    Neurobiol Aging; 2012 Feb; 33(2):426.e1-11. PubMed ID: 21109328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Olfactory screening test in mild cognitive impairment.
    Eibenstein A; Fioretti AB; Simaskou MN; Sucapane P; Mearelli S; Mina C; Amabile G; Fusetti M
    Neurol Sci; 2005 Jul; 26(3):156-60. PubMed ID: 16086128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olfactory dysfunction as a predictor of neurodegenerative disease.
    Albers MW; Tabert MH; Devanand DP
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):379-86. PubMed ID: 16928347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The rhinologic evaluation of Alzheimer's disease.
    Feldman JI; Murphy C; Davidson TM; Jalowayski AA; de Jaime GG
    Laryngoscope; 1991 Nov; 101(11):1198-202. PubMed ID: 1943420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Odor identification deficits in frontotemporal dementia: a preliminary study.
    McLaughlin NC; Westervelt HJ
    Arch Clin Neuropsychol; 2008 Jan; 23(1):119-23. PubMed ID: 17875380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review.
    Kovalová M; Gottfriedová N; Mrázková E; Janout V; Janoutová J
    Otolaryngol Pol; 2024 Apr; 78(2):1-17. PubMed ID: 38623856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases.
    Mesholam RI; Moberg PJ; Mahr RN; Doty RL
    Arch Neurol; 1998 Jan; 55(1):84-90. PubMed ID: 9443714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olfactory dysfunction in aging and neurodegenerative diseases.
    Dan X; Wechter N; Gray S; Mohanty JG; Croteau DL; Bohr VA
    Ageing Res Rev; 2021 Sep; 70():101416. PubMed ID: 34325072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Olfaction and apathy in Parkinson's disease.
    Cramer CK; Friedman JH; Amick MM
    Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.